Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
Author(s) -
Sara Sabbagh,
Adriana A. de Jesus,
SuJin Hwang,
Hye Sun Kuehn,
Hanna Kim,
Lawrence Jung,
Ruy Carrasco,
Sergio D. Rosenzweig,
Raphaela GoldbachMansky,
Lisa G. Rider
Publication year - 2019
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awz293
Subject(s) - tofacitinib , dermatomyositis , autoantibody , juvenile dermatomyositis , medicine , mda5 , dermatology , immunology , antibody , chemistry , rheumatoid arthritis , biochemistry , rna , rna interference , gene
1 Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, USA 2 Translational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA 3 Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA 4 Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD, USA 5 Children’s National Health System, Washington, DC, USA 6 Pediatric Rheumatology, Specialty for Children, Dell Children’s Medical Center, Austin, TX, USA 7 Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), NIH, Bethesda, MD, USA
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom